FDA Announces New Initiatives on Breast Implant Safety

A month after hearing from plastic surgeons, patients and other stakeholders on the topic of breast implant safety, the FDA has announced its first steps toward improving the flow of safety information to patients and physicians.
On Thursday, the FDA issued a statement outlining new steps the agency is taking to protect women considering breast implants and said it will continue to study the array of health conditions and symptoms referred to by some patients and health care professionals as breast implant illness. The agency added that it would also continue to take steps to better characterize the condition and its risk factors.
Read more at the American Society of Plastic Surgeons >>